What is the cause of a severely dilated right ventricle with moderate pulmonary hypertension, mild-to-moderate tricuspid regurgitation (without stenosis), a normal left ventricular ejection fraction of 55–60% and no left-sided heart disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Differential Diagnosis: Severely Dilated RV with Moderate PH and Normal LV Function

The most likely cause is Group 1 pulmonary arterial hypertension (PAH) or Group 4 chronic thromboembolic pulmonary hypertension (CTEPH), which must be distinguished through systematic evaluation including ventilation/perfusion scanning and right heart catheterization. 1

Primary Diagnostic Considerations

The clinical picture of severe RV dilatation with moderate pulmonary hypertension, mild-to-moderate TR, and preserved left ventricular function (EF 55-60%) with no left-sided heart disease points to precapillary pulmonary hypertension as the underlying mechanism.

Key Pathophysiologic Relationships

The TR in this scenario is secondary (functional) rather than primary. Both pulmonary artery pressure and RV dilatation independently determine TR severity 2. The moderate PH creates pressure overload on the RV, while the severe RV dilatation causes:

  • Tricuspid annular dilatation
  • Papillary muscle displacement
  • Leaflet tethering
  • Reduced coaptation area 3

Critical point: The TR is both a consequence of and contributor to RV dysfunction, creating a self-perpetuating cycle where TR increases RV volume overload, worsening chamber dilatation and accelerating disease progression 4.

Systematic Diagnostic Approach

Step 1: Classify the Pulmonary Hypertension Type

According to 2024 guidelines, precapillary PH is defined as:

  • Mean PAP > 20 mm Hg
  • PVR ≥ 2 Wood units
  • PAWP ≤ 15 mm Hg 5

Right heart catheterization is mandatory to confirm hemodynamics and exclude post-capillary causes 5, 6.

Step 2: Distinguish Between Precapillary PH Etiologies

Group 1 (PAH) causes to evaluate:

  • Idiopathic PAH
  • Connective tissue disease (look for telangiectasia, sclerodactyly, digital ulceration suggesting scleroderma) 1
  • HIV infection
  • Portal hypertension/liver disease (spider naevi, palmar erythema, testicular atrophy) 1
  • Congenital heart disease
  • Drug/toxin exposure

Group 4 (CTEPH) - critical not to miss:

  • Requires ventilation/perfusion (V/Q) scanning as CT pulmonary angiography alone may miss the diagnosis 1
  • History of prior pulmonary embolism (though may be absent)
  • This is the only potentially curable form of PH through pulmonary endarterectomy

Group 3 (lung disease-associated):

  • Perform pulmonary function tests with DLCO 1
  • High-resolution CT chest 1
  • Look for inspiratory crackles (interstitial lung disease) or wheeze (though typically absent in pure PAH) 1

Step 3: Assess Disease Severity and Prognosis

The presence of severe TR is an independent predictor of mortality even after adjusting for functional class, 6-minute walk distance, and pulmonary vascular resistance (adjusted HR 1.83,95% CI 1.38-2.41) 7.

Markers of advanced disease:

  • Right atrial dilatation (91% in severe TR vs 47% in mild TR) 7
  • Elevated BNP (695 pg/dL in severe TR vs 328 pg/dL in mild TR) 7
  • Reduced cardiac index (2.2 L/min/m² in severe TR vs 2.8 L/min/m²) 7
  • Shortened 6-minute walk distance 7

Common Pitfalls to Avoid

  1. Assuming TR severity correlates linearly with PA pressure: Many patients with severe PH have only mild TR (65.4% with PASP 50-69 mm Hg have mild TR; 45.6% with PASP ≥70 mm Hg have mild TR) 8. The severe RV dilatation is the key additional factor here.

  2. Skipping V/Q scanning: CT angiography alone misses CTEPH 1, which is the only surgically correctable form.

  3. Relying on echocardiography alone: RHC is essential to confirm hemodynamics, measure true PVR, exclude shunts (as demonstrated in a case where partial anomalous pulmonary venous return was discovered) 6, and perform vasoreactivity testing in PAH 5.

  4. Overlooking pulmonary veno-occlusive disease (PVOD): Consider when digital clubbing is present 1. This has different treatment implications.

Immediate Next Steps

  1. Right heart catheterization with full hemodynamic assessment including vasoreactivity testing if PAH confirmed 5
  2. V/Q scan to exclude CTEPH 1
  3. Comprehensive PAH workup: HIV testing, liver function tests, autoimmune serologies (ANA, anti-Scl-70, anti-centromere), echocardiography for congenital shunts 1
  4. Pulmonary function tests with DLCO and high-resolution CT chest 1
  5. ECG (may show RV hypertrophy, RV strain, right axis deviation, QTc prolongation indicating severe disease) 1

The combination of severe RV dilatation with only moderate PH suggests either longstanding disease with significant RV remodeling or a component of volume overload from the TR itself creating a vicious cycle 4.

References

Research

Impact of pulmonary hypertension on tricuspid valve function.

Annals of biomedical engineering, 2013

Related Questions

What are the causes of severe right ventricular dilation with moderate pulmonary hypertension and mild-to-moderate functional tricuspid regurgitation without stenosis?
In a patient with a 2D echocardiogram showing normal left atrium and left ventricle, no mitral regurgitation, grade I left ventricular systolic dysfunction, severe tricuspid regurgitation, severe pulmonary arterial hypertension with a D‑shaped interventricular septum and pulmonary artery systolic pressure of 84 mmHg, and a hemoglobin of 6.8 g/dL, should a component of left‑heart disease or a hyperdynamic circulation be considered?
In an 85-year-old female with a history of hypertension and moderate tricuspid regurgitation who is currently taking metoprolol succinate (Toprol-XL) 25 mg daily, but now has rising blood pressure (140–160 mm Hg systolic, 90–100 mm Hg diastolic) and tachycardia (heart rate 110–120 bpm) despite unchanged diet, sleep, and activity, what is the appropriate management?
Can Adipex (phentermine) cause severe right‑ventricular dilatation with pulmonary hypertension in a patient who already has a dilated RV, moderate pulmonary hypertension, mild‑to‑moderate functional tricuspid regurgitation, a normal left‑ventricular ejection fraction, and no left‑sided disease?
What is the significance of elevated Pulmonary Artery Systolic Pressure (PASP) with mild Tricuspid Regurgitation (TR)?
In a patient with age‑related macular degeneration (AMD) and glaucoma who has experienced a decline in visual acuity from 6/40 to 6/30, what management steps should be taken?
What are the causes of severe right ventricular dilation with moderate pulmonary hypertension and mild-to-moderate functional tricuspid regurgitation without stenosis?
What is the role of Helicobacter pylori testing and eradication in the work‑up and treatment of immune thrombocytopenia?
What are the causes of hypernatremia in a polytrauma patient?
Can Adipex (phentermine) cause severe right‑ventricular dilatation with pulmonary hypertension in a patient who already has a dilated RV, moderate pulmonary hypertension, mild‑to‑moderate functional tricuspid regurgitation, a normal left‑ventricular ejection fraction, and no left‑sided disease?
What strategies can optimize adaptive servo‑ventilation (ASV) or variable pressure support (VAPS) for a patient with dementia, periodic limb movements, central apneas, and significant mask leak causing tidal‑volume swings, given that lateral positioning improves ventilation but the patient prefers supine?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.